Telemus Capital, LLC Alpha Tau Medical Ltd. Transaction History
Telemus Capital, LLC
- $1.2 Billion
- Q4 2023
A detailed history of Telemus Capital, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Telemus Capital, LLC holds 29,716 shares of DRTS stock, worth $91,525. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,716Holding current value
$91,525% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.36MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$946,5610.07% of portfolio
-
Hoyle Cohen, LLC269KShares$828,7910.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$710,5680.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$204,2840.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$165,1060.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $213M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...